Based on gene expression patterns, breast cancers can be divided into subtypes that closely resemble various developmental stages of normal mammary epithelial cells (MECs). Thus, understanding molecular mechanisms of MEC development is expected to provide critical insights into initiation and progression of breast cancer. Epidermal growth factor receptor (EGFR) and its ligands play essential roles in normal and pathological mammary gland. Signals through EGFR is required for normal mammary gland development. Ligands for EGFR are over-expressed in a significant proportion of breast cancers, and elevated expression of EGFR is associated with poorer clinical outcome. In the present study, we examined the effect of signals through EGFR on MEC d...
We previously demonstrated that the epidermal growth factor receptor (EGFR) modulates in mesenchymal...
The epidermal growth factor receptor (EGFR) has been found to be over expressed in breast cancer and...
Breast cancer is the most common cancer and the second leading cause of cancer mortality in women wi...
<div><p>Mammary gland development and breast cancer growth require multiple factors both of endocrin...
Mammary gland development and breast cancer growth require multiple factors both of endocrine and pa...
Mammary gland development and breast cancer growth require multiple factors both of endocrine and pa...
Differentiation and its therapeutic potential were examined in the context of breast cancer. First, ...
The development of the mammary gland requires an integrated response to specific growth factors and ...
Mammary stem cells (MaSC) are a heterogeneous population that give rise to progenitor cells subseque...
Abstract Background MCF-10A, immortalized but non-transformed human breast epithelial cells, are wid...
The mammary gland is a complex tissue going through cycles of extensive proliferation and differenti...
TGF-β and EGF play critical roles in regulating the metastasis of aggressive breast cancers, yet the...
The ovarian steroid 17β-estradiol (E₂) is critically involved in the growth control of both normal a...
Transforming growth factor-beta (TGF-β) induces the epithelial to mesenchymal transition (EMT) in br...
Introduction: The extracellular signals regulating mammary epithelial cell growth a...
We previously demonstrated that the epidermal growth factor receptor (EGFR) modulates in mesenchymal...
The epidermal growth factor receptor (EGFR) has been found to be over expressed in breast cancer and...
Breast cancer is the most common cancer and the second leading cause of cancer mortality in women wi...
<div><p>Mammary gland development and breast cancer growth require multiple factors both of endocrin...
Mammary gland development and breast cancer growth require multiple factors both of endocrine and pa...
Mammary gland development and breast cancer growth require multiple factors both of endocrine and pa...
Differentiation and its therapeutic potential were examined in the context of breast cancer. First, ...
The development of the mammary gland requires an integrated response to specific growth factors and ...
Mammary stem cells (MaSC) are a heterogeneous population that give rise to progenitor cells subseque...
Abstract Background MCF-10A, immortalized but non-transformed human breast epithelial cells, are wid...
The mammary gland is a complex tissue going through cycles of extensive proliferation and differenti...
TGF-β and EGF play critical roles in regulating the metastasis of aggressive breast cancers, yet the...
The ovarian steroid 17β-estradiol (E₂) is critically involved in the growth control of both normal a...
Transforming growth factor-beta (TGF-β) induces the epithelial to mesenchymal transition (EMT) in br...
Introduction: The extracellular signals regulating mammary epithelial cell growth a...
We previously demonstrated that the epidermal growth factor receptor (EGFR) modulates in mesenchymal...
The epidermal growth factor receptor (EGFR) has been found to be over expressed in breast cancer and...
Breast cancer is the most common cancer and the second leading cause of cancer mortality in women wi...